The FDA has approved Cepheid Xpert C. difficile/Epi assay for the detection of the toxin B gene associated with Clostridium difficile infection. The Cepheid Xpert C. difficile/Epi assay determines if ...

The Food and Drug Administration on Thursday cleared a test made by Cepheid that is aimed at detecting the toxin associated with Clostridium difficile, a bacterium that can cause diarrhea and ...

Results from a comparison study of molecular vs. non-molecular testing for Clostridium difficile toxin have shown that molecular testing detects 35% to 54% more positive specimens than other methods.

A new test is available that can rapidly detect Clostridium difficile and the presence of toxin B gene, a strain of bacteria that causes diarrhea, colitis and in some cases, severe intestinal ...

April 8, 2011 — A rapid diagnostic test for Clostridium difficile has been cleared by the US Food and Drug Administration (FDA). The Cepheid Xpert C difficile/Epi test provides results in less than 45 ...

Please provide your email address to receive an email when new articles are posted on . The FDA announced recently the availability of two new tests to aid in the diagnosis of two infectious diseases ...